TR200003707T2 - Apne , bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı - Google Patents
Apne , bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımıInfo
- Publication number
- TR200003707T2 TR200003707T2 TR2000/03707T TR200003707T TR200003707T2 TR 200003707 T2 TR200003707 T2 TR 200003707T2 TR 2000/03707 T TR2000/03707 T TR 2000/03707T TR 200003707 T TR200003707 T TR 200003707T TR 200003707 T2 TR200003707 T2 TR 200003707T2
- Authority
- TR
- Turkey
- Prior art keywords
- disorders
- norcisapride
- bulimia
- optically pure
- apnea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Child & Adolescent Psychology (AREA)
- Biomedical Technology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Apne, apne bozukluklari, bulimi nervosa, tahrisat yaratabilen bagirsak sendromu, idrarini tutamama, bradikardi, bradiaritmi, sinkop, baska bozukluklar ya da bunlarin semptomlarinin engellenmesi ya da kontrol altina alinmasi için, esas olarak (+) stereoizomerini barindirmayan (-) norsisaprid ya da farmasötik açidan kabul edilebilir bir tuzunun kullanimi.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8922598P | 1998-06-15 | 1998-06-15 | |
US12223699P | 1999-03-01 | 1999-03-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200003707T2 true TR200003707T2 (tr) | 2001-06-21 |
Family
ID=26780367
Family Applications (6)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2000/03707T TR200003707T2 (tr) | 1998-06-15 | 1999-06-10 | Apne , bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2001/03762T TR200103762T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı. |
TR2001/03757T TR200103757T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2001/03758T TR200103758T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı. |
TR2001/03760T TR200103760T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2001/03759T TR200103759T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
Family Applications After (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/03762T TR200103762T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı. |
TR2001/03757T TR200103757T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2001/03758T TR200103758T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı. |
TR2001/03760T TR200103760T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
TR2001/03759T TR200103759T2 (tr) | 1998-06-15 | 1999-06-10 | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı |
Country Status (24)
Country | Link |
---|---|
US (2) | US6559165B1 (tr) |
EP (1) | EP1087765B1 (tr) |
JP (1) | JP2003522103A (tr) |
KR (3) | KR20060020739A (tr) |
CN (1) | CN1312716A (tr) |
AR (1) | AR020327A1 (tr) |
AT (1) | ATE291916T1 (tr) |
AU (1) | AU764474B2 (tr) |
BG (1) | BG105097A (tr) |
BR (1) | BR9911302A (tr) |
CA (1) | CA2334369A1 (tr) |
CZ (1) | CZ20004736A3 (tr) |
DE (1) | DE69924488T2 (tr) |
ES (1) | ES2237117T3 (tr) |
HK (1) | HK1040059A1 (tr) |
HU (1) | HUP0102026A3 (tr) |
IL (1) | IL140117A0 (tr) |
IS (1) | IS5755A (tr) |
NO (1) | NO20006358L (tr) |
NZ (3) | NZ535055A (tr) |
PL (1) | PL345325A1 (tr) |
SK (1) | SK19062000A3 (tr) |
TR (6) | TR200003707T2 (tr) |
WO (1) | WO1999065490A2 (tr) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7160898B2 (en) * | 2001-12-14 | 2007-01-09 | Board Of Trustees Of The University Of Illinois | Pharmacological treatment for sleep apnea |
US6362202B1 (en) * | 1999-03-02 | 2002-03-26 | Sepracor Inc. | Methods and compositions using (−) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
US7846180B2 (en) | 1999-06-22 | 2010-12-07 | Ethicon Endo-Surgery, Inc. | Tissue fixation devices and methods of fixing tissue |
US8287554B2 (en) | 1999-06-22 | 2012-10-16 | Ethicon Endo-Surgery, Inc. | Method and devices for tissue reconfiguration |
US6663639B1 (en) | 1999-06-22 | 2003-12-16 | Ndo Surgical, Inc. | Methods and devices for tissue reconfiguration |
US6835200B2 (en) | 1999-06-22 | 2004-12-28 | Ndo Surgical. Inc. | Method and devices for tissue reconfiguration |
US6821285B2 (en) | 1999-06-22 | 2004-11-23 | Ndo Surgical, Inc. | Tissue reconfiguration |
KR20070087678A (ko) | 2004-12-20 | 2007-08-28 | 컬리지움 파마슈티칼, 인코포레이티드 | 수면 장애용 약제 조성물 |
GB0524668D0 (en) * | 2005-12-02 | 2006-01-11 | Novartis Ag | Organic compounds |
US8852216B2 (en) | 2007-03-23 | 2014-10-07 | Ethicon Endo-Surgery, Inc. | Tissue approximation methods |
Family Cites Families (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR748807A (fr) | 1932-03-10 | 1933-07-10 | Gulf Refining Co | Perfectionnements à la fabrication d'hydrocarbures |
US3536809A (en) | 1969-02-17 | 1970-10-27 | Alza Corp | Medication method |
US3845770A (en) | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
US5137896A (en) | 1981-10-01 | 1992-08-11 | Janssen Pharmaceutica N.V. | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
CA1183847A (en) | 1981-10-01 | 1985-03-12 | Georges Van Daele | N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
US5057525A (en) | 1981-10-01 | 1991-10-15 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl) benzamide derivatives |
US4962115A (en) | 1981-10-01 | 1990-10-09 | Janssen Pharmaceutica N.V. | Novel N-(3-hydroxy-4-piperidinyl)benzamide derivatives |
US4598123A (en) | 1983-07-14 | 1986-07-01 | Unites States Steel Corporation | Impact modified methyl methacrylate polymer |
IE58110B1 (en) | 1984-10-30 | 1993-07-14 | Elan Corp Plc | Controlled release powder and process for its preparation |
US4800162A (en) | 1987-04-01 | 1989-01-24 | Sepracor, Inc. | Method for resolution of steroisomers in multiphase and extractive membrane reactors |
US5057427A (en) | 1988-04-07 | 1991-10-15 | Sepracor, Inc. | Method for resolution of stereoisomers |
US5073543A (en) | 1988-07-21 | 1991-12-17 | G. D. Searle & Co. | Controlled release formulations of trophic factors in ganglioside-lipsome vehicle |
GB8823980D0 (en) * | 1988-10-13 | 1988-11-23 | Glaxo Group Ltd | Chemical compounds |
US5116407A (en) | 1988-10-13 | 1992-05-26 | Courtaulds Coatings Limited | Antifouling coatings |
JPH02188523A (ja) | 1989-01-13 | 1990-07-24 | M S C:Kk | 睡眠時無呼吸症治療薬 |
IT1229203B (it) | 1989-03-22 | 1991-07-25 | Bioresearch Spa | Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative. |
US5075290A (en) | 1989-06-28 | 1991-12-24 | University Of Virginia Alumni Patents Foundation | Use of adenosine, adenosine analogs or nucleoside uptake blockers, e.g. dipyridamole, as drug treatments for obstructive sleep apnea and snoring |
US5120548A (en) | 1989-11-07 | 1992-06-09 | Merck & Co., Inc. | Swelling modulated polymeric drug delivery device |
US5356934A (en) | 1990-03-29 | 1994-10-18 | Eli Lilly And Company | Selected serotonin subtype receptor agonist to treat sleep apnea |
US5733566A (en) | 1990-05-15 | 1998-03-31 | Alkermes Controlled Therapeutics Inc. Ii | Controlled release of antiparasitic agents in animals |
CA2126354C (en) * | 1991-12-21 | 2006-07-11 | Gareth John Sanger | Use of 5-ht4 modulators for the manufacture of a medicament for the treatment of the bladder diseases |
US5580578A (en) | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
JPH08502031A (ja) | 1992-07-07 | 1996-03-05 | セプラコア インコーポレーテッド | 胃食道逆流疾患およびその他の障害を治療するために▲(+)▼シサプリドを使用する方法 |
WO1994001112A1 (en) | 1992-07-07 | 1994-01-20 | Sepracor Inc. | Methods of using (-) cisapride for the treatment of gastro-esophageal reflux disease and other disorders |
US5591767A (en) | 1993-01-25 | 1997-01-07 | Pharmetrix Corporation | Liquid reservoir transdermal patch for the administration of ketorolac |
GB9310756D0 (en) * | 1993-05-25 | 1993-07-14 | Glaxo Lab Sa | Compositions |
CA2166730A1 (en) | 1993-07-06 | 1995-01-19 | Robert T. Sims | H2 antagonist-gastrointestinal motility agent combinations |
US5407953A (en) | 1994-02-04 | 1995-04-18 | Morgan; Julia A. | Treating apnea/hypopnea/snoring in humans |
US5502067A (en) | 1994-02-04 | 1996-03-26 | Morgan; Julia A. | Treating apneahypopnea/snoring in humans |
IT1270594B (it) | 1994-07-07 | 1997-05-07 | Recordati Chem Pharm | Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida |
US5712293A (en) * | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
FR2735475B1 (fr) * | 1995-06-13 | 1997-07-11 | Synthelabo | Derives de n-((1,4-diazabicyclo(2.2.2)oct-2-yl)methyl) benzamide, leur preparation et leur application en therapeutique |
US5739151A (en) * | 1996-07-19 | 1998-04-14 | Sepracor Inc. | Method for treating emesis and central nervous system disorders using optically pure (+) norcisapride |
HUP0003078A3 (en) * | 1997-07-11 | 2002-02-28 | Janssen Pharmaceutica Nv | (+)-norcisapride useful for 5-ht3 and 5-ht4 mediated disorders |
DE69924375T2 (de) | 1998-06-15 | 2005-08-11 | Sepracor Inc. | Verwendung von optisch reinem (+)-norcisapride für die behandlung des reizdarmsyndroms |
-
1999
- 1999-06-10 HU HU0102026A patent/HUP0102026A3/hu unknown
- 1999-06-10 TR TR2000/03707T patent/TR200003707T2/tr unknown
- 1999-06-10 DE DE69924488T patent/DE69924488T2/de not_active Expired - Fee Related
- 1999-06-10 TR TR2001/03762T patent/TR200103762T2/tr unknown
- 1999-06-10 AU AU46784/99A patent/AU764474B2/en not_active Ceased
- 1999-06-10 JP JP2000554370A patent/JP2003522103A/ja active Pending
- 1999-06-10 TR TR2001/03757T patent/TR200103757T2/tr unknown
- 1999-06-10 SK SK1906-2000A patent/SK19062000A3/sk unknown
- 1999-06-10 TR TR2001/03758T patent/TR200103758T2/tr unknown
- 1999-06-10 EP EP99930196A patent/EP1087765B1/en not_active Expired - Lifetime
- 1999-06-10 TR TR2001/03760T patent/TR200103760T2/tr unknown
- 1999-06-10 KR KR1020067003048A patent/KR20060020739A/ko not_active Application Discontinuation
- 1999-06-10 IL IL14011799A patent/IL140117A0/xx unknown
- 1999-06-10 BR BR9911302-3A patent/BR9911302A/pt not_active Application Discontinuation
- 1999-06-10 KR KR1020067010978A patent/KR20060067985A/ko not_active Application Discontinuation
- 1999-06-10 NZ NZ535055A patent/NZ535055A/en unknown
- 1999-06-10 CN CN99809564A patent/CN1312716A/zh active Pending
- 1999-06-10 CA CA002334369A patent/CA2334369A1/en not_active Abandoned
- 1999-06-10 TR TR2001/03759T patent/TR200103759T2/tr unknown
- 1999-06-10 ES ES99930196T patent/ES2237117T3/es not_active Expired - Lifetime
- 1999-06-10 AT AT99930196T patent/ATE291916T1/de not_active IP Right Cessation
- 1999-06-10 KR KR1020007014025A patent/KR20010052740A/ko not_active Application Discontinuation
- 1999-06-10 WO PCT/US1999/013100 patent/WO1999065490A2/en not_active Application Discontinuation
- 1999-06-10 CZ CZ20004736A patent/CZ20004736A3/cs unknown
- 1999-06-10 PL PL99345325A patent/PL345325A1/xx not_active Application Discontinuation
- 1999-06-10 NZ NZ526108A patent/NZ526108A/en unknown
- 1999-06-15 AR ARP990102864A patent/AR020327A1/es unknown
-
2000
- 2000-11-28 US US09/722,391 patent/US6559165B1/en not_active Expired - Fee Related
- 2000-12-08 IS IS5755A patent/IS5755A/is unknown
- 2000-12-12 NZ NZ508825A patent/NZ508825A/en unknown
- 2000-12-13 NO NO20006358A patent/NO20006358L/no unknown
- 2000-12-27 BG BG105097A patent/BG105097A/xx unknown
-
2002
- 2002-03-06 HK HK02101726.7A patent/HK1040059A1/zh unknown
-
2003
- 2003-02-26 US US10/372,875 patent/US7064138B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR200103055T2 (tr) | Apne, bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (+)-norsisapridin kullanımı | |
BR0014178A (pt) | Derivados de ácido dicarboxìlico com propriedades farmacêuticas | |
IL151695A0 (en) | Substituted beta-carbolines with ikb-kinase inhibiting activity | |
TR200200649T2 (tr) | Farmasötik özelliklere sahip olan yeni aminodikarboksilik asit türevleri | |
BR0316169A (pt) | Derivados de indolil pirazinona úteis para tratamento de distúrbios e doenças hiperproliferativos associados com angiogênese | |
MX9703621A (es) | Nuevos derivados aminoacidos con actividad mejorada para la resistencia a drogas multiples. | |
NO992524L (no) | Konsenserte bicykliske pyrimidin-derivater | |
PT1147110E (pt) | Derivados de pirazino (aza)-indol | |
EA199900448A1 (ru) | Производные 6-фенилпиридил-2-амина, полезные в качестве ингибиторов nos | |
TR200003707T2 (tr) | Apne , bulimi ve başka bozuklukların tedavi edilmesi için optik açıdan saf (-) norsisapridin kullanımı | |
HUP9902285A2 (hu) | Hialuronsavformák orálisan adagolható dózisa | |
WO2001081343A3 (en) | Compounds for treating fibromyalgia and chronic fatigue syndrome | |
EA199900542A1 (ru) | Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)-азагетероциклиламида | |
CA2176298A1 (en) | A single high dose fluoroquinolone treatment | |
AP9801202A0 (en) | Atropisomers of 3-heteroaryl-4(3H)-quinazolinones. | |
FI954614A (fi) | Imidatsolokinoksalinonijohdannaiset EAA-antagonisteina | |
BR0116263A (pt) | Derivados de diidroindol e tetraidroquinolina | |
BG105984A (bg) | Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението | |
DE60009315D1 (de) | Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung | |
WO2001008668A3 (en) | Use of 2-amino-4-(4-fluoronaphth-1-yl)-6-isopropylpyrimidine in the treatment of gi disorders | |
BG108033A (en) | Use of 2-amino-1-(4-hydroxy-2-methane sulphonamidophenyl)ethanol for treating urinary incontinence. | |
EP1468685A3 (en) | Use of optically pure (+)-norcisapride for treating apnea, bulimia and other disorders | |
GB9926301D0 (en) | Novel compounds |